𝔖 Bobbio Scriptorium
✦   LIBER   ✦

‘Why do children with cerebral palsy discontinue therapy with botulinum toxin A?’

✍ Scribed by Michaela Linder-Lucht MD; Janbernd Kirschner; Jochen Herrmann; Katrin Geth; Rudolf Korinthenberg; Steffen Berweck; Florian Heinen; Volker Mall

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
402 KB
Volume
48
Category
Article
ISSN
0012-1622

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Motor function following multilevel botu
Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy
✍ Kaat Desloovere; Guy Molenaers; Jos De Cat; Petra Pauwels; Anja Van Campenhout; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB

This study evaluated the effects of multilevel botulinum toxin type A (BTX‐A) treatments on the gait pattern of children with spastic cerebral palsy (Gross Motor Function Classification System Levels I‐III). In this nested case—control design, 30 children (mean age 6y 11mo [SD 1y 5mo]; 21 males, nin

When it comes to botulinum toxin, childr
When it comes to botulinum toxin, children and adults are not the same: Multimuscle option for children with cerebral palsy
✍ Florian Heinen; A. Sebastian Schroeder; Urban Fietzek; Steffen Berweck 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

did not have a peripheral tremor. We considered the diagnosis to be palatopharyngeal myoclonus/tremor and posited a direct relationship to metoclopramide. The drug was stopped and her symptoms subsided over approximately 8 hours. Palatopharyngeal myoclonus is typically a slow form of tremor at 1 to